The United States government is pressing the Australian government to restrict cheap alternatives to brand-name medicines.
United States law allows drug companies to engage in lengthy lawsuits with rival companies once the patent on a drug expires, effectively stopping them from developing cheaper ‘generic’ alternatives. US trade negotiators are seeking similar laws for Australia.
Generic medicines have saved Australians about $2 billion since 1994.
(Source: Herald Sun)